Hodgkin lymphoma Archives - Onco'Zine

Home Tags Hodgkin lymphoma

General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019. ASCO/Luke Franke 2019.

Study Shows Nivolumab Reduces Risk of Disease Progression in Advanced, Untreated...

Editorial Team - June 4, 2023

$FDA Approves Pembrolizumab in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma$

FDA Approves Pembrolizumab in Adult Patients With Relapsed or Refractory Classical...

Editorial Team - October 15, 2020

$Inhibition of HDAC + mTOR May Improve Outcomes in Relapsed/Refractory Hodgkin Lymphoma$

Inhibition of HDAC + mTOR May Improve Outcomes in Relapsed/Refractory Hodgkin...

Editorial Team - October 14, 2020

$Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory Hodgkin Lymphoma$

Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory...

Editorial Team - July 24, 2020

The ASH Store at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center. Photo courtesy © 2019. ASH/Scott Morgan.

ASH 2019: Brentuximab Vedotin in Combination with Nivolumab in Frontline and...

Editorial Team - December 8, 2019

Brentuximab Vedotin Included in New Supplemental BLA for Peripheral T-cell Lymphoma

Peter Hofland - November 7, 2018

Case Reports Show Potential of Cancer Immunotherapy for the Treatment of...

Sonia Portillo - July 11, 2017

BMS and Seattle Genetics Expand Evaluate Combination of Nivolumab + Brentuximab...

Peter Hofland - June 3, 2017

Study Links Higher Rates of Hodgkin Lymphoma Relapse in Pediatric Patients...

Peter Hofland - December 26, 2012

Majority of Pediatric Patients with Hodgkin Lymphoma Achieve CR After Treatment...

Peter Hofland - September 24, 2011

LATEST NEWS

DNADX® Test Significantly Correlates with Patient Outcomes in Clinical Studies

Editorial Team - December 7, 2023

No differences Between Palbociclib-letrozole and Palbociclib-fulvestrant in HR+/HER2- advanced BC

Editorial Team - December 7, 2023

Drug Combination Shows Promise in Treatment of Nerve Sheath Tumors

Editorial Team - December 1, 2023

Genomic Nasal Swab Test may Improve Lung Cancer Risk Assessment for Smokers with Lung...

Editorial Team - November 30, 2023

Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery

Peter Hofland - November 25, 2023

Press Releases | Cancer

Transform Any Spectrophotometer with FireflySci's Micro Focus Cell Conversion Kit December 11, 2023
In this day and age, people are always looking to go smaller and more powerful. FireflySci is proud to release their Micro Focus Cell conversion kit which easily transforms any standard spectrophotometer into a micro-drop machine. NORTHPORT, N.Y., Dec. 11, 2023 /PRNewswire-PRWeb/ --...
Beauty-Stem Biomedical US Inaugurates Los Angeles Laboratory for Holistic Health Condition Testing December 10, 2023
Beauty-Stem Biomedical takes a groundbreaking leap in redefining wellness with the establishment of a cutting-edge laboratory in Los Angeles. This state-of-the-art facility is set to transform health assessment, reflecting the company's unwavering commitment to scientific excellence. LOS...
Call Box Releases Web Form Leads to Revolutionize Healthcare Lead Management December 9, 2023
Call Box is pleased to introduce an innovative feature - Web Form Leads. DALLAS, Dec. 9, 2023 /PRNewswire-PRWeb/ -- In an ongoing effort to transform patient lead management, Call Box is pleased to introduce an innovative feature - Web Form Leads. In response to the growing need for an...